Zarate, C. A., & Machado-Vieira, R. (2016). GSK-3: A key regulatory target for ketamine’s rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput. Bipolar Disord.
Styl ChicagoZarate, Carlos A., a Rodrigo Machado-Vieira. "GSK-3: A Key Regulatory Target for Ketamine’s Rapid Antidepressant Effects Mediated By Enhanced AMPA to NMDA Throughput." Bipolar Disord 2016.
Citace podle MLAZarate, Carlos A., a Rodrigo Machado-Vieira. "GSK-3: A Key Regulatory Target for Ketamine’s Rapid Antidepressant Effects Mediated By Enhanced AMPA to NMDA Throughput." Bipolar Disord 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..